N@N

ISTA, CHDN, GYB, TCBI, PTIE, CNMD Are Seasonally Ripe To Go Up In the Next Five Weeks

September 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ISTA PHARMACEUTICALS INC (NASDAQ:ISTA), CHURCHILL DOWNS INC (NASDAQ:CHDN), Corporate Asset Backed Corp. CABCO Series 2004101 Trust (NYSE:GYB), TEXAS CAPITAL BANCSHARES INC (NASDAQ:TCBI), PAIN THERAPEUTICS INC (NASDAQ:PTIE), CONMED CORP (NASDAQ:CNMD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     ISTA       ISTA PHARMACEUTICALS INC            6.69%               90.91% (10 of 11)       Friday, September 30th 2011
     CHDN       CHURCHILL DOWNS INC                 3.38%               90.91% (10 of 11)       Friday, September 30th 2011
     GYB        Corporate Asset Backed Corp. CABCO Series 2004101 Trust     1.75%               100.00% (7 of 7)        Wednesday, October 19th 2011
     TCBI       TEXAS CAPITAL BANCSHARES INC        2.43%               87.50% (7 of 8)         Thursday, September 29th 2011
     PTIE       PAIN THERAPEUTICS INC               5.56%               81.82% (9 of 11)        Monday, October 3rd 2011
     CNMD       CONMED CORP                         3.11%               81.82% (9 of 11)        Thursday, September 29th 2011

ISTA PHARMACEUTICALS INC (NASDAQ:ISTA) - ISTA Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and markets remedies for diseases and conditions of the eye in the United States. It provides products to treat diseases of the eye and allergies; and therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. The company offers Xibrom for the treatment of ocular inflammation and pain following cataract surgery; Bepreve to treat ocular itching associated with allergic conjunctivitis; Istalol for the treatment of Glaucoma; and Vitrase for use as a spreading agent. Its products under development include XiDay, which completed Phase III confirmatory clinical study for the treatment of ocular inflammation and pain following cataract surgery; T-Pred that completed Phase III bioequivalence study for the treatment of steroid-responsive inflammatory ocular conditions; Bromfenac lower concentration, which completed Phase II study to treat dry eye syndrome; Ecabet Sodium, a Phase IIb product for the treatment of dry eye syndrome; and Bepotastine Nasal to treat allergic rhinitis. The companys products under development also comprise a steroid product candidate to treat ocular inflammation; iganidipine to enhance ocular nerve blood flow; and a formulation of latanoprost, a prostaglandin, for the treatment of glaucoma. ISTA Pharmaceuticals, Inc. sells its products primarily to drug wholesalers, retailers, and distributors, including large chain drug stores, hospitals, clinics, government agencies, and managed healthcare providers. The company was formerly known as Advanced Corneal Systems, Inc. and changed its name to ISTA Pharmaceuticals, Inc. in March 2000. ISTA Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Irvine, California.

CHURCHILL DOWNS INC (NASDAQ:CHDN) - Churchill Downs Incorporated owns and operates pari-mutuel wagering properties and businesses in the United States. It offers gaming products through its slot and video poker operations in Louisiana and Florida. The company manages operations through Churchill Downs Racetrack, a thoroughbred racing operation in Louisville, Kentucky; Arlington Park Racecourse, a thoroughbred racing in Arlington Heights with 10 off-track betting (OTB) facilities in Illinois; Calder Race Course, a thoroughbred racing in Miami Gardens, Florida; Fair Grounds Race Course, a thoroughbred racing in New Orleans with 11 OTBs and a slot facility with approximately 600 slot machines and 3 restaurants in Louisiana; and Video Services, Inc., the owner and operator of approximately 800 video poker machines in Louisiana. Churchill Downs Incorporated also owns interests in Churchill Downs Simulcast Productions, LLC, which provides television production and integration of computer graphic software to the racing industry; and HRTV, LLC, a horseracing television channel. In addition, it operates online business through TwinSpires, an advance deposit wagering business; and Bloodstock Research Information Services, a data service provider for the equine industry. The company was founded in 1928 and is based in Louisville, Kentucky.

Corporate Asset Backed Corp. CABCO Series 2004101 Trust (NYSE:GYB) - Corporate Asset Backed Corp. CABCO Series 2004101 Trust

TEXAS CAPITAL BANCSHARES INC (NASDAQ:TCBI) - Texas Capital Bancshares, Inc. operates as the holding company for Texas Capital Bank, National Association that provides various banking and financial services for middle market commercial and high net worth customers in Texas. It primarily engages in generating deposits and originating loans. The companys deposit products include checking accounts, savings accounts, money market accounts, and certificates of deposit, as well as commercial checking accounts, lockbox accounts, cash concentration accounts, and other cash management products. Its lending activities comprise commercial loans and leases; real estate loans, including loans secured by properties and temporary financing for commercial and residential property; construction loans consisting of single-family residential properties and commercial projects; loans held for sale; and letters of credit. The company also offers various trust services, including investment management, personal trust and estate services, custodial services, and related services, as well as retirement products, such as individual retirement accounts and administrative services for retirement vehicles, such as pension and profit sharing plans. Texas Capital Bancshares, Inc. has banking offices in Dallas, Houston, Fort Worth, Austin, and San Antonio. As of December 31, 2009, it operated nine full service banking locations and one operations center. The company was founded in 1996 and is headquartered in Dallas, Texas.

PAIN THERAPEUTICS INC (NASDAQ:PTIE) - Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of novel drugs. It has four drug candidates in clinical development programs, which include Remoxy, a novel controlled-release oral capsule form of oxycodone; PTI-202 and PTI-721, which are abuse-resistant forms of opioid drugs; and PTI-188 for the treatment of metastatic melanoma. The company is also developing a technology for the treatment of hemophilia in patients. Pain Therapeutics, Inc. has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy, PTI-202, PTI-721, and other abuse-resistant opioid painkillers. The company was founded in 1998 and is based in San Mateo, California.

CONMED CORP (NASDAQ:CNMD) - CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The companys products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery, and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants and related disposable products, and fluid management systems; powered surgical instruments used to perform orthopedic, arthroscopic, and other surgical procedures; and electrosurgery products comprising pencils, active electrodes, ground pads, generators, coagulation systems, and smoke evacuation systems. The companys patient care products comprise a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products used in critical care areas. It also provides endosurgical products, such as clip appliers and laparoscopic instruments; and cutting trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles, and linear cutters and staplers. In addition, the company offers endoscopic technology products comprising forceps, accessories, bronchoscopy devices, dilatation, hemostasis, biliary devices, and polypectomy for the diagnosis and treatment of gastrointestinal and pulmonary disorders. Its products are used by surgeons and physicians in various specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company operates primarily in the United States, Canada, the United Kingdom, Japan, and Australia. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641